In PD, DRP1-mediated mitochondrial fragmentation is associated with dopaminergic neuronal loss, and inhibiting DRP1 or promoting mitochondrial fusion has demonstrated neuroprotective effects in PD models [89]. This evidence concerns the gene DNM1L and Parkinson disease.